Bellevue Group AG Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$551.1B
Holdings
130
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (130 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GILDGilead Sciences, Inc. | 233,300 | $21.4B | 3.89% | |
| 2 | CELGCelgene Corporation | 210,550 | $21.1B | 3.82% | |
| 3 | MDTMedtronic, Inc. | 276,500 | $20.7B | 3.76% | |
| 4 | BIIBBiogen Inc. | 76,540 | $19.9B | 3.62% | |
| 5 | ABTAbbott Laboratories | 381,500 | $16.0B | 2.90% | |
| 6 | AMGNAmgen Inc. | 103,000 | $15.4B | 2.80% | |
| 7 | BDXBecton, Dickinson and Company | 100,225 | $15.2B | 2.76% | |
| 8 | ILMNIllumina, Inc. | 91,625 | $14.9B | 2.70% | |
| 9 | SYKStryker Corporation | 125,000 | $13.4B | 2.43% | |
| 10 | CAHCardinal Health, Inc. | 159,630 | $13.1B | 2.37% | |
| 11 | UNHUnitedHealth Group Incorporated | 93,000 | $12.0B | 2.18% | |
| 12 | REGNRegeneron Pharmaceuticals, Inc. | 32,400 | $11.7B | 2.12% | |
| 13 | TEVATeva Pharmaceuticals Industries Ltd | 195,290 | $10.4B | 1.90% | |
| 14 | —Mylan Inc. | 220,000 | $10.2B | 1.85% | |
| 15 | BSXBoston Scientific Corporation | 500,000 | $9.4B | 1.71% | |
| 16 | ZBHZimmer Biomet Holdings, Inc. | 86,200 | $9.2B | 1.67% | |
| 17 | CVSCVS Health Corporation | 86,200 | $8.9B | 1.62% | |
| 18 | LGNDLigand Pharmaceuticals Incorporated | 81,830 | $8.8B | 1.59% | |
| 19 | JAZZJazz Pharmaceuticals Public Limited Company | 62,500 | $8.2B | 1.48% | |
| 20 | —Auris Medical Holding AG | 2,169,625 | $7.9B | 1.43% | |
| 21 | ISRGIntuitive Surgical, Inc. | 13,000 | $7.8B | 1.42% | |
| 22 | ALXNAlexion Pharmaceuticals, Inc. | 49,400 | $6.9B | 1.25% | |
| 23 | MCKMcKesson Corporation | 43,000 | $6.8B | 1.23% | |
| 24 | SUPNSupernus Pharmaceuticals, Inc. | 441,000 | $6.7B | 1.22% | |
| 25 | —St. Jude Medical, Inc. | 122,000 | $6.7B | 1.22% | |
| 26 | INCYIncyte Corporation | 91,000 | $6.6B | 1.20% | |
| 27 | CICigna Corporation | 48,000 | $6.6B | 1.20% | |
| 28 | CNCCentene Corporation | 105,880 | $6.5B | 1.18% | |
| 29 | EWEdwards Lifesciences Corporation | 73,000 | $6.4B | 1.17% | |
| 30 | CHRSCoherus BioSciences, Inc | 287,000 | $6.1B | 1.11% | |
| 31 | —Shire PLC | 33,880 | $5.8B | 1.06% | |
| 32 | ISIIonis Pharmaceuticals Inc. | 138,000 | $5.6B | 1.01% | |
| 33 | HUMHumana, Inc. | 30,000 | $5.5B | 1.00% | |
| 34 | JNJJohnson & Johnson | 50,000 | $5.4B | 0.98% | |
| 35 | —Mallinckrodt public limited company | 88,000 | $5.4B | 0.98% | |
| 36 | BMRNBioMarin Pharmaceutical Inc. | 65,000 | $5.4B | 0.97% | |
| 37 | BAXBaxter International Inc. | 130,000 | $5.3B | 0.97% | |
| 38 | VRTXVertex Pharmaceuticals Incorporated | 66,000 | $5.2B | 0.95% | |
| 39 | —Horizon Pharma plc | 310,000 | $5.1B | 0.93% | |
| 40 | BCRUSDC.R. Bard, Inc. | 25,000 | $5.1B | 0.92% | |
| 41 | —Aetna Inc. | 45,000 | $5.1B | 0.92% | |
| 42 | —Endo International PLC | 171,000 | $4.8B | 0.87% | |
| 43 | HCAHCA Holdings, Inc. | 60,000 | $4.7B | 0.85% | |
| 44 | INSYEURInsys Therapeutics, Inc. | 281,000 | $4.5B | 0.82% | |
| 45 | PRGOPerrigo Company plc | 32,600 | $4.2B | 0.76% | |
| 46 | ELVAnthem, Inc. | 30,000 | $4.2B | 0.76% | |
| 47 | —Express Scripts Holding Company | 58,600 | $4.0B | 0.73% | |
| 48 | —Intersect Ent, Inc. | 209,246 | $4.0B | 0.72% | |
| 49 | BMYBristol-Myers Squibb Company | 60,000 | $3.8B | 0.70% | |
| 50 | EGBNEagle Pharmaceuticals Inc | 93,400 | $3.8B | 0.69% | |
| 51 | COOCooper Companies Inc. | 23,500 | $3.6B | 0.66% | |
| 52 | —Impax Laboratories, Inc. | 108,000 | $3.5B | 0.63% | |
| 53 | PFEPfizer Inc. | 110,000 | $3.3B | 0.59% | |
| 54 | —Achillion Pharmaceuticals, Inc. | 420,000 | $3.2B | 0.59% | |
| 55 | CYHCommunity Health Systems, Inc. | 174,840 | $3.2B | 0.59% | |
| 56 | CERNCHFCerner Corporation | 60,000 | $3.2B | 0.58% | |
| 57 | MRKMerck & Co., Inc. | 60,000 | $3.2B | 0.58% | |
| 58 | —ARIAD Pharmaceuticals, Inc. | 495,000 | $3.2B | 0.57% | |
| 59 | 3M4Masimo Corporation | 75,000 | $3.1B | 0.57% | |
| 60 | HALOHalozyme Therapeutics, Inc. | 318,000 | $3.0B | 0.55% | |
| 61 | —Novadaq Technologies Inc. | 270,000 | $3.0B | 0.54% | |
| 62 | NKTREURNektar Therapeutics | 216,000 | $3.0B | 0.54% | |
| 63 | VAREURVarian Medical Systems, Inc. | 37,000 | $3.0B | 0.54% | |
| 64 | ABGAmerisourceBergen Corporation | 34,000 | $2.9B | 0.53% | |
| 65 | NUVAGBPNuvasive, Inc. | 60,000 | $2.9B | 0.53% | |
| 66 | —Medivation, Inc. | 63,000 | $2.9B | 0.53% | |
| 67 | TMOThermo Fisher Scientific Inc. | 20,000 | $2.8B | 0.51% | |
| 68 | HOLXHologic, Inc. | 81,000 | $2.8B | 0.51% | |
| 69 | NBIXNeurocrine Biosciences, Inc. | 65,000 | $2.6B | 0.47% | |
| 70 | LLYLilly Eli & Co. | 35,000 | $2.5B | 0.46% | |
| 71 | SGENEURSeattle Genetics, Inc. | 68,000 | $2.4B | 0.43% | |
| 72 | UTHUnited Therapeutics Corporation | 19,300 | $2.3B | 0.42% | |
| 73 | INOInovio Pharmaceuticals, Inc. | 265,000 | $2.3B | 0.42% | |
| 74 | ALKSAlkermes Public Limited Company | 65,500 | $2.2B | 0.41% | |
| 75 | AGIOAgios Pharmaceuticals, Inc. | 54,000 | $2.2B | 0.40% | |
| 76 | GMEDGlobus Medical, Inc. | 87,700 | $2.1B | 0.38% | |
| 77 | QGENQiagen NV | 91,500 | $2.0B | 0.37% | |
| 78 | —Zeltiq Aesthetics Inc. | 75,000 | $2.0B | 0.37% | |
| 79 | LN5Lannett Inc. | 107,810 | $1.9B | 0.35% | |
| 80 | ANGOAngioDynamics, Inc. | 151,400 | $1.9B | 0.34% | |
| 81 | HCSGHealthcare Services Group Inc. | 50,000 | $1.8B | 0.33% | |
| 82 | ICPTUSDIntercept Pharmaceuticals, Inc. | 13,500 | $1.7B | 0.31% | |
| 83 | NVAXNovavax, Inc. | 325,000 | $1.7B | 0.30% | |
| 84 | TFXTeleflex Incorporated | 10,010 | $1.6B | 0.29% | |
| 85 | MGNXMacrogenics, Inc. | 83,000 | $1.6B | 0.28% | |
| 86 | ALNYAlnylam Pharmaceuticals Inc. | 24,000 | $1.5B | 0.27% | |
| 87 | DVADavita Healthcare Partners, Inc. | 20,000 | $1.5B | 0.27% | |
| 88 | —Juno Therapeutics, Inc. | 37,000 | $1.4B | 0.26% | |
| 89 | DC4DexCom, Inc. | 20,000 | $1.4B | 0.25% | |
| 90 | PRTAProthena Corporation plc | 31,000 | $1.3B | 0.23% | |
| 91 | ACADAcadia Pharmaceuticals, Inc. | 45,000 | $1.3B | 0.23% | |
| 92 | —Radius Health Inc. | 40,000 | $1.3B | 0.23% | |
| 93 | —Bluebird Bio, Inc. | 29,000 | $1.2B | 0.22% | |
| 94 | —Laboratory Corporation of America Holdings | 10,000 | $1.2B | 0.21% | |
| 95 | —Wright Medical Group Inc. | 70,309 | $1.2B | 0.21% | |
| 96 | CLVSEURClovis Oncology, Inc. | 52,500 | $1.0B | 0.18% | |
| 97 | —Quotient Limited | 100,000 | $880.0M | 0.16% | |
| 98 | ABBVAbbvie Inc. | 15,000 | $857.0M | 0.16% | |
| 99 | INFIQInfinity Pharmaceuticals, Inc. | 160,000 | $843.0M | 0.15% | |
| 100 | —Alder Biopharmaceuticals Inc. | 33,000 | $808.0M | 0.15% |
Page 1 of 2Next